Potential Depressive Central Nervous System Effects of Brimonidine Topical Gel
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Haber R, El Gemayel M
. Comorbidities in rosacea: A systematic review and update. J Am Acad Dermatol. 2017; 78(4):786-792.e8.
DOI: 10.1016/j.jaad.2017.09.016.
View
2.
Lipner S
. Novel Use of Brimonidine 0.33% Gel for Hemostasis in Nail Surgery. Dermatol Surg. 2018; 45(7):993-996.
DOI: 10.1097/DSS.0000000000001632.
View
3.
Meana J, Barturen F, Garcia-Sevilla J
. Alpha 2-adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression. Biol Psychiatry. 1992; 31(5):471-90.
DOI: 10.1016/0006-3223(92)90259-3.
View
4.
Shagalov D, Taylor D, Schleichert R, Weiss J, Weiss E
. Association of Central Nervous System Depression With Topical Brimonidine When Used for Hemostasis: A Serious Adverse Event. JAMA Dermatol. 2017; 153(6):575-577.
PMC: 5817602.
DOI: 10.1001/jamadermatol.2017.0247.
View
5.
Docherty J, Steinhoff M, Lorton D, Detmar M, Schafer G, Holmes A
. Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine Therapy. Adv Ther. 2016; 33(11):1885-1895.
PMC: 5083782.
DOI: 10.1007/s12325-016-0404-8.
View